Mrs Amiee Kang
Bristol-Myers Squibb, Lawrenceville (United States of America)
Real-world assessment of anti-platelet therapies for recurrent stroke prevention in non-atrial fibrillation Japanese patients after recent ischemic stroke or transient ischemic attack
Event: ESC Congress 2022
Topic: Cardiovascular Pharmacotherapy
Session: Short and long-term antiplatelet therapy in clinical practice
Comparative effectiveness and safety of non-VKA oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with differential treatment duration: an ARISTOPHANES study analysis
Event: ESC Congress 2019
Topic: Oral Anticoagulation
Session: Atrial fibrillation and oral anticoagulation 6
ESC 365 is supported by
